اختبار التليف الكبدي YRA317 // YRA321

The Hepatic Fibrosis Test YRA317 // YRA321 is an essential tool in the early detection and management of liver fibrosis. Designed to work seamlessly with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, this test highlights the importance of early diagnosis in reversing or delaying liver fibrosis progression. The test is targeted at improving patients' quality of life by enabling prompt intervention before reaching the more critical stages of liver disease, such as cirrhosis.

Market Price

Hepatic fibrosis tests like the YRA317 and YRA321 typically range in price depending on the quantity and specific model. In the market, you can expect these tests to be priced competitively due to their advanced features and certifications. For the most accurate pricing, we encourage you to request a quote through the Kalstein Plus platform.

Frequently Asked Questions

• What is hepatic fibrosis? Hepatic fibrosis is the scarring process of the liver as a result of chronic liver damage.
• How does this test work? The test uses a chemiluminescence immunoassay (CLIA) to measure particular markers related to liver fibrosis.
• How should I store the test kits? The kits should be stored at temperatures between 2-8°C.
• Are there any certifications for this product? Yes, these tests come with CE, ISO13485, and FSC certifications.

Advantages and Disadvantages

Advantages: The tests offer high precision and are easy to use in clinical settings. They are compatible with widely-used analyzers, ensuring an easy integration into existing workflows. Disadvantages: As with any specific diagnostic tool, these tests require appropriate equipment and trained staff to conduct and interpret the results accurately.

Field Use

In practical scenarios, the Hepatic Fibrosis Test YRA317 // YRA321 is utilized in medical labs for patients exhibiting symptoms or risk factors associated with liver disease. The quick turnaround on results allows healthcare providers to make timely decisions regarding patient care and treatment strategies.

Recommendations

For optimal results when using the Hepatic Fibrosis Test YRA317 // YRA321, it is recommended to adhere strictly to storage guidelines and ensure regular calibration of equipment. Consider scheduling periodic training for laboratory personnel to maintain proficiency in handling and analyzing test results. Request a quote or initiate an automatic quote with Kalstein Plus today and take the first step towards enhancing patient care.

Features

• Compatible with YR06389 and YR06390 Analyzers
• Multiple tested parameters: PIIINP, CIV, LN, HA, CG
• Uses CLIA technology
• Available in multiple packaging sizes
• Certified by CE, ISO13485, FSC

Technical Specifications